業績

2023, Maeda H, Shingai R, Takeda K, Hara A, Murai Y, Ofuchi M. Assessment of Surrogate End Point Trends in Clinical Trials to Approve Oncology Drugs From 2001 to 2020 in Japan. JAMA Netw Open. 2023 Apr 3;6(4):e238875.

Assessment of Surrogate End Point Trends in Clinical Trials to Approve Oncology Drugs From 2001 to 2020 in Japan | Oncology | JAMA Network Open | JAMA Network

代替エンドポイントに基づく癌治療薬承認の実態:日経メディカル (nikkeibp.co.jp)